We have a charming little tradition here at Stock Gumshoe of picking out the stinkiest stock to have been teased over the past year, and calling it our “Turkey of the Year” come Thanksgiving time. It’s not particularly fair — certainly not to turkeys everywhere, and probably not to the newsletter folks who use breathless, […]
Articles
Those who’ve been with the Gumshoe for a while know that it’s tough to top Stansberry’s Phase 1 Investor for marketing that uses over-the-top hyperbole about tiny biotech and mining stocks, and creative names that obscure the truth behind their investments — that doesn’t seem to have changed much with the new(ish) guy at the […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
$ACIU: A new biotech IPO stock debuted last Friday, September 23: AC Immune, based in Switzerland, is a clinical-stag...
Two biotech IPOs this week might be of some interest. I've personally not been participating in the biotech IPO market b...
Krystyna: I know of AC Immune. My truthful feeling is that its clinical programs are also-rans. Little distinguishes th...
Just read that a company called AC Immune has just filed its F-1 paperwork with the U.S. Securities & Exchange Commissio...